IL-2 activated cell-mediated immunotherapy: Control of minimal residual disease in malignant disorders by allogeneic lymphocytes and IL-2

  • S. Slavin
  • , A. Ackerstein
  • , E. Kedar
  • , L. Weiss

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'IL-2 activated cell-mediated immunotherapy: Control of minimal residual disease in malignant disorders by allogeneic lymphocytes and IL-2'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Veterinary Science and Veterinary Medicine

Immunology and Microbiology